Ethyl 2,4,5-trifluorobenzoylacetate (CAS 98349-24-7; C11H9F3O3, molecular weight 246.19) is the fluorinated aromatic beta-ketoester that serves as the classic side-chain building block for fluoroquinolone-class antibacterial active substances. Its structure combines a 2,4,5-trifluorophenyl ring with a reactive beta-ketoester chain, so one molecule delivers both the fluorinated aromatic pharmacophore fragment and the three-carbon unit that is cyclised into the quinolone core. Commercial material is generally supplied as a low-melting to waxy crystalline solid, reported to melt in the 45 to 55 degrees Celsius range, with the exact form depending on purity and thermal history.
Supply is anchored in Chinese fluoro-aromatics capacity, where chlorination, fluorination and Friedel-Crafts or Claisen chemistry are integrated at scale, with Indian API and intermediate producers in Hyderabad, Gujarat and Maharashtra converting the ketoester into quinolone intermediates and active substances, and a smaller European tier serving captive, generic and R&D campaigns. Buyers qualify on enol-content control, isomer and homologue profile, residual fluorinated aromatics and metal content, and because the material feeds antibacterial APIs, qualification is inseparable from antimicrobial-resistance and API-discharge compliance.
The 2026 regulatory position requires an honest boundary statement. This molecule carries three aromatic carbon-fluorine bonds and a fluorinated ring, but no perfluoroalkyl chain: it is a polyfluorinated aromatic, not a perfluoroalkyl substance in the OECD core sense, and it falls outside the principal scope of the EU universal PFAS restriction proposal and of the PFOA and PFHxA restrictions. It is nevertheless routinely captured by brand and buyer PFAS questionnaires, by TSCA section 8(a)(7) reporting scoping and by trifluoroacetic-acid degradation scrutiny.
Two structural elements drive behaviour. The aromatic ring carries three fluorines, which withdraw electron density and make the attached carbonyl strongly electrophilic while also blocking the metabolic soft spots that make unfluorinated aromatics easy to oxidise. The beta-ketoester chain supplies an acidic methine flanked by two carbonyls, giving a carbon-acid site for cyclisation chemistry. Together they make the molecule a bis-electrophile and a carbon nucleophile, which is exactly the reactivity profile needed to build a quinolone ring.
Manufacture has two distinct halves that many producers keep in one site: building the 2,4,5-trifluorinated aromatic ring by halogen-exchange fluorination, and installing the three-carbon beta-ketoester chain by condensation chemistry. The second half is classical organic chemistry; the first half is fluorination engineering, and it is where most of the capital, the hazard and the environmental liability sit.
Demand is driven by antibacterial API volumes, generic competition and public-health procurement rather than by fashion in medicinal chemistry. That exposure cuts both ways. Stewardship programmes and the WHO AWaRe framework restrain inappropriate fluoroquinolone use, which caps volume growth in some markets, while the same policies and the EU pharmaceutical strategy for Europe sustain strategic demand for secure, audited supplies of essential antibacterials. Demand is therefore stable but policy-sensitive, and buyers increasingly prefer suppliers who document environmental performance as well as quality.
Capacity follows fluoro-aromatics capability, and China holds the dominant position, with integrated chlorination, fluorination and condensation assets in Jiangsu, Shandong, Zhejiang and Liaoning that reach back to anhydrous hydrogen fluoride and fluorspar. India is the largest converter, with Hyderabad, Gujarat and Maharashtra API producers buying the ketoester or making it captively and building quinolone active substances for domestic and export markets. Europe retains limited, compliance-intensive capacity and remains an importer. Export flows therefore run from Chinese fluoro-aromatics plants to Indian API sites and to European and North American finished-dose and API customers.
Two tiers coexist. Technical grade at 97 to 98 percent with a declared assay basis trades on fluoro-aromatics margins, off hydrogen fluoride, chlorinated precursor and solvent cost, and is sensitive to environmental-compliance cost in China. GMP-aligned pharmaceutical grade at 99 percent plus, with validated methods, ICH M7 assessment, ICH Q3D elemental data and DMF or CEP support, commands a substantial premium and is sold on audit outcome. Since 2024 the gap has widened as fluorine emission control, waste treatment and documentation costs rose while technical-grade capacity expanded.
Three regulatory layers apply. The substance itself needs a correct GHS classification, a destination-language SDS, a tonnage-appropriate REACH position for the EU and a correct TSCA inventory position for the United States. Because it is fluorinated, it is drawn into PFAS-adjacent questionnaires and reporting scoping broader than the scientific perfluoroalkyl definition. And because it feeds antibacterial APIs, customers impose environmental-residue and discharge expectations that reach back up the supply chain. It is not an approved drug substance itself and is supplied as an industrial intermediate.
Environmental pressure on this chemistry is unusually intense, because fluorine emissions and antibacterial API residues are both politically visible. Buyers increasingly request quantified evidence rather than assurances, so a supplier holding per-campaign fluorine mass balance and adsorbable organic fluorine discharge data clears procurement screens that price alone cannot.
Most cradle-to-gate footprint sits in anhydrous hydrogen fluoride production, in the energy-intensive halogen-exchange step and in solvent recovery, rather than in the condensation chemistry. Levers are solvent recovery by distillation, heat integration, hydrogen fluoride recovery from off-gas, and calcium-fluoride precipitation that converts fluoride burden into a stable solid rather than dissolved effluent. Scope 1 and Scope 2 accounting is standard in questionnaires and Scope 3 fluorspar data is increasingly requested.
Fluorspar is a European Union critical raw material and export licensing in producing countries can tighten quickly, so upstream traceability is supply security as much as ESG. Buyers should require current ISO 9001 and ISO 14001 certificates, third-party environmental and GMP audit reports, the hydrogen fluoride and chlorinated precursor source, and an account of fluorinated waste destination including incineration with hydrogen fluoride scrubbing. Chain-of-custody documents should follow each lot: batch number, certificate of analysis, fluorine mass-balance summary and a signed PFAS declaration.
This material is a low-melting solid that can be shipped as a solid or, if warmed, handled as a liquid, which makes physical-form control the central logistics issue: melting and re-solidifying in transit changes appearance and assay homogeneity. Packaging must exclude moisture, storage must hold a controlled band below the melting range, and the shipment must respect the environmental-hazard classification the certified data supports.
Shippers must obtain a certified classification for the specific formulation: polyfluorinated aromatic ketoesters are frequently consigned under an irritant or environmentally-hazardous-substance UN entry, with the packing group set by certified data and the exact UN number taken from the shipper's dangerous-goods declaration rather than assumed. Transport follows ADR and RID in Europe, the IMDG Code at sea and IATA DGR for air. Requirements include UN-specification packaging with valid test certificates, segregation from bases and oxidisers, temperature-monitored stowage below the melting range, and emergency information referencing hydrogen fluoride generation under fire conditions.
Three priorities decide who wins: GMP-grade documentation that survives an API customer audit, a fluorine and AMR-linked environmental dossier that survives a buyer questionnaire, and physical-form control that survives transit.
Ethyl 2,4,5-trifluorobenzoylacetate is a structurally irreplaceable side-chain building block whose demand rests on fluoroquinolone antibacterial production and on fluorinated heterocycle discovery. Its 2026 risk profile is dominated by definition, documentation and environmental performance rather than by synthesis capability: enol-content specification, ICH M7 and Q3D evidence, fluorine mass balance, TFA-generation data, a defensible PFAS declaration and environmental-residue data that support the customer's own risk assessment.
For buyers the recommendation is to qualify on the full analytical package, to audit hydrogen fluoride handling and fluorinated waste treatment, to require thermal and physical-form data before approving any isolation or shipping step, and to contract around documented GMP campaigns with dual sourcing across China and India. That buys reproducibility and regulatory defensibility, which matter more than price for an intermediate feeding an essential antibacterial API.
Powered by Guidechem
This white paper is exclusively compiled by the Guidechem Intelligence Team based on global customs data, regulatory databases, and industry research. Guidechem is a leading global B2B chemical platform, dedicated to connecting global buyers with verified, high-quality manufacturers.
Relying on Guidechem's extensive global database, we have mapped the core participants in the current global Ethyl 2,4,5-trifluorobenzoylacetate supply chain:
Disclaimer: The content of this white paper is compiled based on public market data and regulatory information available as of 2026. Global chemical regulations are subject to dynamic adjustments. In actual export operations, enterprises must consult professional regulatory advisors or relevant competent authorities to obtain the latest compliance guidance.
![]() |